Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 29, 1999

View Archived Issues

Published Data Show Infliximab Also Helps Stop Joint Damage

CAT Partners With Searle In Deal Worth Up To US$150M

MorphoSys, Bayer Form Broad Collaboration Around Antibodies

UK Genomics Initiative Involves Collection Of DNA For Database

Paladin Acquires Neurocrine Program To Broaden Pipeline

Juvantia Pharma Enters Clinic With Anti-Parkinson's Candidate

Australian Researchers Discover Genes Linked To Obesity, Testes

Matrix Moves Right Into Clinic Following Recent Formation

Evotec Enters Agreement To Screen 10 Targets For Knoll

European Patent Board Affirms Patentability Of Plants, Animals

NicOx Begins Phase II Study Of Paget's Disease Candidate

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...